{"disease":{"id":"stargardt-macular-degeneration","name":"stargardt macular degeneration"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06375239","title":"Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ray Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02875704","title":"Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy","phase":"","overall_status":"TERMINATED","enrollment_count":77,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06942572","title":"A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Splice Bio","has_results":false},{"nct_id":"NCT06445322","title":"Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ascidian Therapeutics, Inc","has_results":false},{"nct_id":"NCT05674058","title":"Function and Imaging Assessments for G1961E-associated Stargardt Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT06467344","title":"Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Ascidian Therapeutics, Inc","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}